The latest progress report from the National Antibiotic Resistance Monitoring System (NARMS) included data enhanced through the use of whole genome sequencing technology. According to the FDA, comprehensive genetic data can reveal new features of resistant foodborne bacteria that cause human illness, and that information strengthens the scientific basis for regulatory decisions.

To inform stakeholders on the role genomic technology in resistance research, the FDA will host a webcast titled “Next Grand Rounds: Antibiotic resistance surveillance in the age of genomics: New answers to old questions.” The webcast will take place on Thursday, May 12, 2016 at 12:00 to 1:00 pm Eastern time.

The FDA, USDA, and CDC launched NARMS, an interagency collaborative effort, in 1996 to monitor resistance in bacteria from retail meats, food-producing animals, and human clinical cases of infection.

NARMS director Dr. Patrick McDermott will present the webcast. McDermott has directed the program since 2008. He is past Deputy Director of the Office of Research at FDA’s Center for Veterinary Medicine. A Microbiologist by training, he has 25 years of experience researching antimicrobial resistance. He represents FDA as a member of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) and on the Steering Committee of the WHO Global Foodborne Infections Network (GFN). Dr. McDermott is a member of the Interagency and Transatlantic Task Forces on Antimicrobial Resistance.

Click here to register for the webcast.